Clinical utility of procalcitonin as a marker of sepsis: A potential predictor of causative pathogens

Internal Medicine

Volumn 53, Issue 14, 2014, Pages 1497-1503

  Nakajima, Atsuko ^a   Yazawa, Junko ^a   Sugiki, Daisuke ^a   Mizuguchi, Mari ^a   Sagara, Hironori ^a   Fujisiro, Masahiro ^a   Shibazaki, Mitsuei ^a   Hitani, Akihiko ^a   To, Masako ^a   Haruki, Kosuke ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bacterial blood culture; Procalcitonin; Sepsis

Indexed keywords

BIOLOGICAL MARKER; ENDOTOXIN; PROCALCITONIN; C REACTIVE PROTEIN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GRAM NEGATIVE SEPSIS; GRAM POSITIVE COCCI; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PNEUMONIA; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; BLOOD; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; LEUKOCYTE COUNT; METABOLISM; MICROBIOLOGY; MIDDLE AGED; REPRODUCIBILITY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEPSIS;

EID: 84904352394     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1785     Document Type: Article

References (24)

1. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113: 227-242, 1990.
2. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31: 2742-2751, 2003.
3. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7: 210-217, 2007.
4. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515-518, 1993.
5. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and metaanalysis. Lancet Infect Dis 13: 426-435, 2013.
6. Endo S, Kasai T, Inada K. Evaluation of procalcitonin levels in patients with systemic inflammatory response syndrome as the diagnosis of infection and the severity of illness. Kansenshogaku Zasshi (The Journal of the Japanese Association for Infectious Diseases) 73: 197-204, 1999 (in Japanese, Abstract in English).
7. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34: 2596-2602, 2006.
8. Theodorou VP, Papaioannou VE, Tripsianis GA, et al. Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study. BMC Infect Dis 12: 247, 2012.
9. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36: 941-952, 2008.
10. Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134: 49-55, 1999.
11. Kapoor S. Procalcitonin and its utility as a diagnostic and prognostic assay in patients with renal dysfunction and immunosuppressive conditions. J Infect Chemother 15: 58, 2009.
12. No authors listed. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874, 1992.
13. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96: 644-647, 2007.
14. Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 11: 152-159, 2005.
15. Buhaescu I, Yood RA, Izzedine H. Serum procalcitonin in systemic autoimmune diseases: where are we now? Semin Arthritis Rheum 40: 176-183, 2010.
16. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8: R234-R242, 2004.
17. Gibot S, Bene MC, Noel R, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit CareMed 186: 65-71, 2012.
18. Jekarl DW, Lee SY, Lee J, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 75: 342-347, 2013.
19. Tamaki K, Kogata Y, Sugiyama D, et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 35: 114-119, 2008.
20. Hirakata Y, Yanagihara K, Kurihara S, et al. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with communityacquired pneumonia. Diagn Microbiol Infect Dis 61: 170-174, 2008.
21. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24: 888-889, 1998.
22. Kaur K, Mahajan R, Tanwar A. A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting. Int J Appl Basic Med Res 3: 77-83, 2013.
23. Hohn A, Schroeder S, Gehrt A, et al. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC Infect Dis 13: 158, 2013.
24. Schuetz P, Raad I, Amin DN. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care 19: 453-460, 2013.